Please assess the completion status of the following clinical trial:

Trial Title: Ceftriaxone in the Management of Bipolar Depression

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* DSM-IV diagnosis of bipolar disorder~* Presence of a current major depressive episode on the SCID~* Score of 17 or greater on the HDRS~* Failure to respond to two previous medication trials~* Capable of giving voluntary written consent~Exclusion Criteria:~* Hypersensitivity to penicillin or cephalosporin, resulting in anaphylaxis~* Significant current substance dependence/abuse within 3 months preceding the trial~* Significant history of intravenous drug abuse~* Active suicidal ideation~* Pregnant/lactating mothers~* Significant medical history~* Patients on anticoagulation treatment~* Patients who test positive for HIV or Hep B or C

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- A (Type: ACTIVE_COMPARATOR): None
- P (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).